R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer. Ter Steege EJ, Boer M, Timmer NC, Ammerlaan CM, et al. J Pathol 2022 Aug 9. doi: 10.1002/path.5999.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ter Steege EJ, Boer M, Timmer NC, Ammerlaan CM, et al. R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer. J Pathol 2022 Aug 9. doi: 10.1002/path.5999.
PMID: 36106661